Yu Sawada

1.2k total citations
29 papers, 631 citations indexed

About

Yu Sawada is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu Sawada has authored 29 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu Sawada's work include Pancreatic and Hepatic Oncology Research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Yu Sawada is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Yu Sawada collaborates with scholars based in Japan, United States and United Kingdom. Yu Sawada's co-authors include Itaru Endo, Takafumi Kumamoto, Daisuke Morioka, Georgios Antonios Margonis, Nikolaos Andreatos, Timothy M. Pawlik, Kazunari Sasaki, Simone Conci, Calogero Iacono and Andrea Ruzzenente and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Surgery.

In The Last Decade

Yu Sawada

28 papers receiving 623 citations

Peers

Yu Sawada
J. Furuse Japan
Yu Sawada
Citations per year, relative to Yu Sawada Yu Sawada (= 1×) peers J. Furuse

Countries citing papers authored by Yu Sawada

Since Specialization
Citations

This map shows the geographic impact of Yu Sawada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Sawada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Sawada more than expected).

Fields of papers citing papers by Yu Sawada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Sawada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Sawada. The network helps show where Yu Sawada may publish in the future.

Co-authorship network of co-authors of Yu Sawada

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Sawada. A scholar is included among the top collaborators of Yu Sawada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Sawada. Yu Sawada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murakami, Takashi, Yasuhiro Yabushita, Yuki Homma, et al.. (2025). Efficacy of Conversion Surgery for Initially Unresectable Biliary Tract Cancer That Has Responded to Down-Staging Chemotherapy. Cancers. 17(5). 873–873. 1 indexed citations
2.
Sahara, Kota, T Takahashi, Kentaro Miyake, et al.. (2023). Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis. Journal of Clinical Medicine. 12(7). 2654–2654. 9 indexed citations
3.
Matsuyama, Ryusei, Rintaro Mori, Yuki Homma, et al.. (2022). Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma. Annals of Surgical Oncology. 29(4). 2393–2405. 13 indexed citations
4.
Takeda, Kazuhisa, Yu Sawada, Yasuhiro Yabushita, et al.. (2022). Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: A retrospective cohort study. World Journal of Gastrointestinal Oncology. 14(7). 1281–1294. 5 indexed citations
5.
Kumamoto, Takafumi, et al.. (2022). Surgical Indications for Huge Hepatocellular Carcinoma. Anticancer Research. 42(5). 2573–2581. 1 indexed citations
6.
Sawada, Yu, et al.. (2022). Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases. Anticancer Research. 42(11). 5497–5505. 6 indexed citations
7.
Tsuchiya, Nobuhiro, Ryusei Matsuyama, Takashi Murakami, et al.. (2020). Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long‐Term Chemotherapy. World Journal of Surgery. 44(8). 2752–2760. 9 indexed citations
8.
Abe, Yuka, Takafumi Kumamoto, Kentaro Miyake, et al.. (2020). A case of triple digestive tract reconstruction in chronic pancreatitis complicated with bile ductal stenosis, duodenal stenosis, and portal vein stenosis: a case report. SHILAP Revista de lepidopterología. 6(1). 116–116.
9.
Hiroshima, Yukihiko, Rintaro Mori, Yusuke Saigusa, et al.. (2019). MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients. Annals of Surgical Oncology. 26(13). 4506–4514. 10 indexed citations
10.
Tsuchiya, Nobuhiro, Ryusei Matsuyama, Takashi Murakami, et al.. (2019). Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy and Curative Resection. Anticancer Research. 39(8). 4431–4440. 8 indexed citations
11.
Oshi, Masanori, Georgios Antonios Margonis, Yu Sawada, et al.. (2018). Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis. Annals of Surgical Oncology. 26(2). 593–603. 23 indexed citations
12.
Furuya, Mitsuko, Rintaro Mori, Yasuhiro Yabushita, et al.. (2018). Medullary carcinoma of the pancreas radiologically followed up as a cystic lesion for 9 years: a case report and review of the literature. SHILAP Revista de lepidopterología. 4(1). 80–80. 9 indexed citations
13.
Nakagawa, Kazuya, Kuniya Tanaka, Kazunori Nojiri, et al.. (2017). Predictive factors for bile leakage after hepatectomy for hepatic tumors: a retrospective multicenter study with 631 cases at Yokohama Clinical Oncology Group (YCOG). Journal of Hepato-Biliary-Pancreatic Sciences. 24(1). 33–41. 19 indexed citations
14.
Yoshikawa, Toshiaki, Yu Sawada, Manami Shimomura, et al.. (2016). Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model. Biochemistry and Biophysics Reports. 5. 482–491. 13 indexed citations
15.
Takeda, Kazuhisa, Yu Sawada, Takafumi Kumamoto, et al.. (2016). Successful multidisciplinary treatment of refractory cytomegalovirus infection after living donor liver transplantation using mixed lymphocyte reactions: report of a case. Clinical Journal of Gastroenterology. 9(1). 38–42. 1 indexed citations
16.
Sasaki, Kazunari, Daisuke Morioka, Simone Conci, et al.. (2016). The Tumor Burden Score. Annals of Surgery. 267(1). 132–141. 273 indexed citations
17.
Takeda, Kazuhisa, Yu Sawada, Takafumi Kumamoto, Karo Tanaka, & Itaru Endo. (2016). Severe Sepsis After Living Donor Liver Transplantation: Risk Factors and Outcomes. Transplantation Proceedings. 48(6). 2124–2129. 12 indexed citations
18.
Uchida, Tetsuya, Yu Sawada, Nobuhiro Tsuchiya, et al.. (2015). Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice. Biochemical and Biophysical Research Communications. 469(1). 138–143. 17 indexed citations
19.
Sawada, Yu, Toshiaki Yoshikawa, Satoshi Fujii, et al.. (2013). Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination. Human Vaccines & Immunotherapeutics. 9(6). 1228–1233. 22 indexed citations
20.
Yoshida, Keisuke, Yu Sawada, Seiichi Ikeda, et al.. (2010). Multiscale fabrication of a transparent circulation type blood vessel simulator. Biomicrofluidics. 4(4). 46505–46505. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026